Pulmonary hypertension in patients with chronic obstructive pulmonary disease: advances in pathophysiology and management.
about
Pulmonary vasculature in COPD: The silent componentCOPD immunopathologyDust events, pulmonary diseases and immune systemSubcellular and cellular locations of nitric oxide synthase isoforms as determinants of health and diseaseCT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD.Adenosine A2B receptor and hyaluronan modulate pulmonary hypertension associated with chronic obstructive pulmonary diseaseEfficacy of inhaled iloprost in cor pulmonale and severe pulmonary hypertension associated with tuberculous destroyed lung.Cigarette smoke exposure up-regulates endothelin receptor B in human pulmonary artery endothelial cells: molecular and functional consequencesDefective alterations in the collagen network to prostacyclin in COPD lung fibroblasts.Pulmonary artery distensibility in chronic obstructive pulmonary disease.The crossroads of iron with hypoxia and cellular metabolism. Implications in the pathobiology of pulmonary hypertension.The interaction of endothelin-1 and TGF-β1 mediates vascular cell remodeling.Effects of different pulmonary vasodilators on arterial saturation in a model of pulmonary hypertension.IL-18 induces emphysema and airway and vascular remodeling via IFN-γ, IL-17A, and IL-13Pulmonary Hypertension Secondary to COPD.A Functional Variant rs6435156C > T in BMPR2 is Associated With Increased Risk of Chronic Obstructive Pulmonary Disease (COPD) in Southern Chinese PopulationMechanics and mechanisms of pulmonary hypertension-Conference summary and translational perspectives.Cigarette Smoke Disrupted Lung Endothelial Barrier Integrity and Increased Susceptibility to Acute Lung Injury via Histone Deacetylase 6Activation of RhoA/Rho-kinase pathway accounts for pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary diseasePrevalence and Characteristics of Pulmonary Hypertension Associated with COPD - A Pilot Study in Patients Referred to a Pulmonary Rehabilitation Program ClinicRelationship between polycythemia and in-hospital mortality in chronic obstructive pulmonary disease patients with low-risk pulmonary embolismThe Effects of Statins on Pulmonary Artery Pressure in Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial.Analysis of V/Q-matching--a safety "biomarker" in pulmonary drug development?Multiple facets of cAMP signalling and physiological impact: cAMP compartmentalization in the lung.Low WSS and High OSI Measured by 3D Cine PC MRI Reflect High Pulmonary Artery Pressures in Suspected Secondary Pulmonary Arterial HypertensionCOPD-associated pulmonary hypertension: clinical implications and current methods for treatment.State of the Art Review of the Right Ventricle in COPD Patients: It is Time to Look Closer.Phosphodiesterase-4 inhibition improves corticosteroid insensitivity in pulmonary endothelial cells under oxidative stress.LPS enhances TLR4 expression and IFN‑γ production via the TLR4/IRAK/NF‑κB signaling pathway in rat pulmonary arterial smooth muscle cells.Probable Phaeoacremonium parasiticum as a cause of cavitary native lung nodules after single lung transplantation.Animal models of cigarette smoke-induced chronic obstructive pulmonary disease.Right ventricular outflow tract function in chronic obstructive pulmonary disease.Stimulation of soluble guanylate cyclase prevents cigarette smoke-induced pulmonary hypertension and emphysema.Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension.Plasma myostatin levels are related to the extent of right ventricular dysfunction in exacerbation of chronic obstructive pulmonary disease.Phosphodiesterase-5 Inhibition Alleviates Pulmonary Hypertension and Basal Lamina Thickening in Rats Challenged by Chronic Hypoxia.
P2860
Q26749309-CC94D73E-020F-410D-B2A9-F6902D860940Q26749575-C41F3269-BB3F-456C-8648-DBCF440A0A2CQ26852090-4E9A6AF3-1196-4B39-9173-E09DDE023A46Q28279612-9E78C378-5010-4D0F-8822-81CF9EC9A282Q30415182-F57A73A9-B7C5-4959-B5DD-0D4153B5372CQ33765096-B41B1D4B-1865-40EB-BA11-8D78B816066AQ33896324-57F2C47C-12C6-4E04-ABC3-43C5ECB9C230Q34442358-B83D06B7-96D0-421A-A737-232124AE20A3Q34585087-8EA3F872-9580-4EC6-AE0A-BFC9F803FDACQ34620137-747FF129-C575-44B7-9BFE-01077A070E46Q34924892-595FD8A4-071E-41B3-97BE-09FD8E2464D5Q34981727-8252ADF0-91F0-4BB9-AE6C-504D2F954F72Q34981737-1BE747E7-37F8-4355-80DC-5958ACB61460Q36026286-BD7B61BB-0AC1-4C16-8BBA-32C59FA33943Q36221051-7263ACE5-827E-4C84-AB3D-1075B080AAE8Q36754116-29934A0D-B493-46B9-88F7-AB6CBD307988Q36810785-E609C7EB-D22D-413B-9EE6-64F0F5C554B8Q37088228-4EC88166-7CD6-459D-B674-1BC1DAF95A3AQ37344140-0EAE8F34-0CDC-4C99-88B4-25CB604BF54AQ37405956-9D9EFE7B-D619-4CD1-A503-06A129834AA4Q37528325-DD7D7FFF-A583-432D-A2AE-19A8B29B05C8Q37697923-DD46F864-C643-4762-B17A-8E4FA4911678Q37894734-223D7B68-A4DE-488E-B862-B77386BC6CCDQ38166604-DFC6CAA6-3C56-4161-8A6B-384DDD67687CQ38633315-AC91A170-0949-4887-9D03-E69FA09AD07AQ38841456-6CFE77A1-4D66-404C-9302-1337A528A072Q39028640-2850F282-780C-4C04-8029-F23F7455A46EQ39526549-A75957CC-0D31-4F2A-BF3E-8E0F8FA17DF5Q42546814-83899054-05FE-422A-90B3-6B349C9DE7C4Q43838739-E09BA1E9-A648-462C-B0E8-6982BC306EF2Q44892855-6C38F21A-7986-4002-B9B3-43ABA4809CFDQ45213136-4036411C-E430-45FA-9C42-D3885DAF8235Q46455331-4F46D537-5BE9-48AB-ADB6-AC5FB9D99BDBQ47137930-9A8655EE-FDDC-4BC9-B302-892F43132141Q51504349-094A4DB3-93AA-4D55-A7AF-1121819B0146Q52325761-A569265C-4D19-492B-B26C-763807299C7A
P2860
Pulmonary hypertension in patients with chronic obstructive pulmonary disease: advances in pathophysiology and management.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pulmonary hypertension in pati ...... athophysiology and management.
@en
Pulmonary hypertension in pati ...... athophysiology and management.
@nl
type
label
Pulmonary hypertension in pati ...... athophysiology and management.
@en
Pulmonary hypertension in pati ...... athophysiology and management.
@nl
prefLabel
Pulmonary hypertension in pati ...... athophysiology and management.
@en
Pulmonary hypertension in pati ...... athophysiology and management.
@nl
P2860
P921
P1433
P1476
Pulmonary hypertension in pati ...... athophysiology and management.
@en
P2093
Isabel Blanco
Joan Albert Barberà
P2860
P304
P356
10.2165/00003495-200969090-00002
P577
2009-06-01T00:00:00Z
P6179
1019761495